Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
2.560
-0.200 (-7.25%)
At close: Apr 1, 2025, 4:00 PM
2.690
+0.130 (5.08%)
Pre-market: Apr 2, 2025, 6:18 AM EDT

Terns Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
223471401504179-
Upgrade
Market Cap Growth
17.33%17.33%-20.44%182.18%--
Upgrade
Enterprise Value
-133991353181-
Upgrade
Last Close Price
2.565.546.4910.187.07-
Upgrade
PS Ratio
---178.64-
Upgrade
PB Ratio
0.641.361.571.821.11-
Upgrade
P/TBV Ratio
1.361.361.571.821.11-
Upgrade
EV/Sales Ratio
---1.44-
Upgrade
Debt / Equity Ratio
0.000.000.000.00-0.19
Upgrade
Asset Turnover
----0.01-
Upgrade
Quick Ratio
22.8922.8922.0633.4324.343.28
Upgrade
Current Ratio
23.1423.1422.3933.6824.483.98
Upgrade
Return on Equity (ROE)
-29.56%-29.56%-33.89%-27.60%-43.83%-68.73%
Upgrade
Return on Assets (ROA)
-20.13%-20.13%-23.08%-17.04%-23.94%-39.83%
Upgrade
Return on Capital (ROIC)
-21.11%-21.11%-24.00%-17.68%-25.78%-46.38%
Upgrade
Earnings Yield
-39.76%-18.88%-22.49%-11.97%-28.08%-
Upgrade
FCF Yield
-31.35%-14.89%-16.82%-9.80%-23.61%-
Upgrade
Buyback Yield / Dilution
-11.57%-11.58%-97.76%-58.69%-7862.47%-55.60%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q